Single agent gefitinib as first line therapy in patients with advanced non-small cell lung cancer: Washington University experience.
Lung Cancer. 2004 Aug;45(2):221-5. doi: 10.1016/j.lungcan.2004.01.022.
Lung Cancer. 2004.
PMID: 15246194